A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

NCT07533006 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: LY4005130
DRUG: Placebo

Sponsor

Eli Lilly and Company